FURLAN, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 1.949
EU - Europa 471
AS - Asia 287
AF - Africa 9
SA - Sud America 9
OC - Oceania 3
Totale 2.728
Nazione #
US - Stati Uniti d'America 1.925
IT - Italia 166
SG - Singapore 131
IN - India 92
UA - Ucraina 74
SE - Svezia 67
CN - Cina 48
FI - Finlandia 43
DE - Germania 25
CA - Canada 23
IE - Irlanda 18
GB - Regno Unito 17
BG - Bulgaria 14
RU - Federazione Russa 13
BE - Belgio 10
ID - Indonesia 8
AR - Argentina 7
RO - Romania 6
TG - Togo 6
FR - Francia 4
AU - Australia 3
RS - Serbia 3
BJ - Benin 2
GR - Grecia 2
IL - Israele 2
MY - Malesia 2
NL - Olanda 2
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 2.728
Città #
Fairfield 325
Woodbridge 196
Ashburn 138
Chandler 128
Houston 120
Ann Arbor 115
Singapore 102
Seattle 100
Wilmington 94
Cambridge 77
Rome 74
Princeton 48
Dearborn 40
Plano 40
Santa Clara 39
Jacksonville 33
Lawrence 28
Beijing 24
Millbury 22
San Paolo di Civitate 22
Boston 20
Dublin 18
San Diego 17
Sofia 14
Andover 13
New York 13
Des Moines 12
Helsinki 12
Toronto 12
Fremont 9
Ottawa 9
Brussels 8
Jakarta 8
Moscow 8
Norwalk 8
Federal 7
Mannheim 7
Boardman 6
Hefei 6
Lomé 6
Phoenix 6
Bremen 5
Bari 4
San Mateo 4
Auburn Hills 3
Falkenstein 3
Falls Church 3
Frankfurt am Main 3
Los Angeles 3
Mumbai 3
Nanjing 3
Naples 3
Selevac 3
Athens 2
Barletta 2
Chicago 2
Fasano 2
Florence 2
Indiana 2
Kraainem 2
Livorno 2
Nantes 2
New Delhi 2
Parma 2
Pune 2
San Jose 2
Scarborough 2
Southend 2
Turin 2
Atlanta 1
Atri 1
Baotou 1
Belize City 1
Bratislava 1
Brentford 1
Brno 1
Buffalo 1
Changsha 1
Colombo 1
Dallas 1
Dongying 1
Fiano Romano 1
Grafing 1
Gravina In Puglia 1
Guangzhou 1
Guayaquil 1
Haifa 1
Hengshui 1
Huizhou 1
Hyderabad 1
Jinan 1
Leawood 1
London 1
Madrid 1
Melbourne 1
Melun 1
Munich 1
Nanyang 1
Newark 1
Ningbo 1
Totale 2.087
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 146
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 139
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 107
HCC in the era of direct-acting antiviral agents (DAAs): surgical and other curative or palliative strategies in the elderly 96
Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey 92
IL28B Gene Polymorphisms and US Liver Fatty Changes in Patients Who Spontaneously Cleared Hepatitis C Virus Infection 80
Acute hepatitis B in patients with or without underlying chronic HCV infection 79
Alfacon-1 IFN daily in HCV chronic hepatitis 76
Ultrasound evaluation of liver fibrosis: preliminary experience with acoustic structure quantification (ASQ) software 76
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 75
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 75
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b 71
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy 71
EFFICACY OF ENTECAVIR AS RESCUE THERAPY IN LAMIVUDINE-RESISTANT PATIENTS WITH HBV LIVER CIRRHOSIS AND WIATING FOR ORTHOTOPIC LIVER TRANSPLANTATION 70
Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveys 70
"Toxic erythema" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient 70
ENTECAVIR NELLA TERAPIA DELL'EPATITE B CRONICA 69
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 69
Hepatitis delta infection in Italian patients: towards the end of the story? 67
Entecavir therapy for lamivudine resistant HBV cirrhotic patients waiting for OLT: viral and biochemical outcomes at one year 66
Anti-GOR antibodies in anti-hepatitis C virus positive subjects with and without virus replication and liver disease. 65
Liver cirrhosis: Epidemiological aspects in Italy 65
null 63
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy 61
Mortality Risk According to Different Clinical Characteristics of First Episode of Liver Decompensation in Cirrhotic Patients: A Nationwide, Prospective, 3-Year Follow-Up Study in Italy 58
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis 54
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study 53
Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma 51
Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment. 50
Prevalence of HCV-positive status and Genotype in B-cell non-Hodgkin's lymphoma patients in a population from cantral Italy 49
null 49
Epatite cronica delta: interferone pegilato alfa2b una nuova opzione terapeutica? 47
null 47
Elderly and very elderly patients with hepatocellular carcinoma. Strategy for a first line treatment. 47
OSSERVAZIONI PRELIMINARI SULL'USO DELL'ATAZANAVIR IN PAZIENTI CON INFEZIONE DA HIV PRETRATTATI 46
Demographic., etiological and clinical features of liver cirrhosis at the onset of first episode of clinical decompensation: preliminary results of the AISF-EPASCO Collaborative Study Group 38
Osservazioni prelimiari sull'uso di Atazanavir in pazienti con infezione da HIV pretrattati 37
Influence of universal HBV vaccination on chronic HBV infection in Italy: results of a cross-sectional multicenter study 36
Detection rate of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: an updated systematic review and meta-analysis 36
Influence of HCV Genotype 1a and Genotype 1b on the virological response to antiviral therapy 32
null 31
Low rate of one-year mortality in patients with stage 4 cirrhosis: the Italian Association for the Study of the Liver (A.I.S.F.)-EPASCO prospective multicenter 26
Profili psicologici al test MMPI2 di pazienti epatopatici sottoposti a terapia interferonica: confronto tra soggetti con e senza precedenti disturbi mentali 26
Necessità di follow-up serrato in pazienti HIV-HCV: studio preliminare su un campione di popolazione di coinfetti 24
Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium 21
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology 18
Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy 14
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience 13
Totale 2.821
Categoria #
all - tutte 7.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020457 0 0 0 0 0 105 81 79 62 53 53 24
2020/2021278 32 22 13 21 1 18 11 19 27 77 19 18
2021/2022473 16 26 42 18 52 8 9 48 32 28 112 82
2022/2023447 90 77 39 36 54 50 4 32 41 2 15 7
2023/2024180 20 21 7 13 11 33 5 12 0 18 17 23
2024/2025224 20 73 26 21 43 41 0 0 0 0 0 0
Totale 2.821